An annotated guideline to the use of a health economics analysis plan (heap) alongside randomised controlled trial
Health economists working on clinical trial based economic evaluations are often asked at a preliminary stages of studies, and sometimes before data are available, to propose a plan for the collection and analysis of information on resource use, costs and quality of life. Questions that frequently a...
| Главные авторы: | , , , , |
|---|---|
| Формат: | Conference item |
| Опубликовано: |
BioMed Central
2017
|